Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Rubrik Inc. Class A Common Stock (RBRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Rubrik Inc. Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.8 (market cap $6.04B), while Rubrik Inc. Class A Common Stock trades at $122.29 (market cap $25.06B). The key difference: Rubrik Inc. Class A Common Stock is far larger — about 4.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 2,394,852). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Rubrik Inc. Class A Common Stock for 0 Days on average.
| IOVA | RBRK | |
|---|---|---|
Market Cap | $6.04B | $25.06B |
Volume | 14,805,993 | 2,394,852 |
Sector | Health | Technology |
52-Week High | $14.82 | $125.80 |
52-Week Low | $1.81 | $43.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $24.46B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Rubrik Inc. Class A Common Stock
Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.
Read more on RBRK →
